Sarabia, Naomi A.
HRN: 26-09-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/21/2024
11/23/2024
IV
600mg
Every 6hours For 6doses Only
S/P Debridement, Left Foot
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes